[Reticular hyperplasia following hydantoin derivatives].
D000293:Adolescent; D002675:Child, Preschool; D003937:Diagnosis, Differential; D003875:Drug Eruptions / Q000175:diagnosis / Q000209:etiology*; D004487:Edema / Q000150:complications; D004827:Epilepsy / Q000188:drug therapy; D005076:Exanthema / Q000139:chemically induced / Q000150:complications; D005260:Female; D005334:Fever / Q000150:complications; D006529:Hepatomegaly / Q000150:complications; D006801:Humans; D006827:Hydantoins / Q000009:adverse effects* / Q000627:therapeutic use; D006965:Hyperplasia; D008206:Lymphatic Diseases / Q000139:chemically induced / Q000150:complications; D008223:Lymphoma / Q000139:chemically induced; D008297:Male; D011230:Precancerous Conditions / Q000139:chemically induced; D012878:Skin Neoplasms / Q000175:diagnosis; D013163:Splenomegaly / Q000150:complications; D014402:Tuberous Sclerosis / Q000188:drug therapy
D006827:Hydantoins
Retikuläre Hyperplasie als Komplikation nach Hydantoinderivaten